This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Crinetics Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Alan S. Krasner: Innovator in Medical Treatments
Introduction
Alan S. Krasner is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of diseases related to ACTH excess. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Alan S. Krasner holds a patent for a Melanocortin subtype-2 receptor (MC2R) antagonist aimed at treating diseases such as Cushing's disease, ectopic ACTH syndrome, and congenital adrenal hyperplasia. This patent represents a breakthrough in therapeutic methods and compositions for managing these conditions. He has 1 patent to his name.
Career Highlights
Krasner is currently associated with Crinetics Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions for endocrine disorders, showcasing his commitment to improving patient outcomes.
Collaborations
One of his notable collaborators is Christine Ferrara-Cook, with whom he has worked closely to further their research initiatives. Their partnership exemplifies the collaborative spirit in the scientific community.
Conclusion
Alan S. Krasner's contributions to medical science through his patent and work at Crinetics Pharmaceuticals, Inc. highlight his role as an innovator in the treatment of serious health conditions. His dedication to advancing medical treatments continues to make a significant impact in the field.